In the last few months, the VT team has been reviewing numerous reports and initial data from doctors around the world, concerning diseases related to lesions of epithelial cells and microvascular tissue, caused by the virus of COVID-19.
Venturis Therapeutics, Inc. ("VT") announced today that it has applied for four provisional patents relating to the treatment and / or prevention of virus-induced diseases related to the COVID- 19, as well as other viruses. These new patent applications include the following general areas: cardiac injury and virus-induced stroke; severe acute respiratory syndrome (SARS ); intestinal dysfunction or damage to intestinal epithelial cells; and renal dysfunction or failure.
In the last few months, the VT team has been reviewing numerous reports and initial data from doctors around the world, concerning diseases related to lesions of epithelial cells and microvascular tissue, caused by the virus of COVID-19. Lesions are recorded in patients of different age groups, during and after the apparent recovery from the COVID-19 virus and in patients who have experienced severe or only mild symptoms of the virus. The presentation of virus-induced diseases can include, without limitation, strokes, organ failure, fibrosis, sudden blood clots and ischemia of cells and tissues. VT has many years of experience in the use of therapeutic angiogenesis in the treatment and regeneration of ischemic and / or injured epithelial cells and microvascular tissues.
VT hopes that these new patents, combined with other VT patents, such as its current stroke-related patents, will allow VT to expand the development of current and discovered methods and therapies to treat potentially fatal diseases and distressing, in large patient populations. With these proposed and existing patents, VT seeks to position itself at the forefront of private sector companies, which are combating the devastating effects of these diseases.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Severity: Warning
Message: count(): Parameter must be an array or an object that implements Countable
Filename: amp/news_details_amp.php
Line Number: 252
Backtrace:
File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler
File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view
File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.
media@smartmarketnews.com | sales@smartmarketnews.com
Contact Us